Okay, let's tackle this question. The question is about the pharmacological closure of a patent ductus arteriosus (PDA) in a premature infant. So, first, I need to recall what medications are used for this condition.

I remember that PDA is a common issue in preemies because the ductus arteriosus usually closes after birth. If it stays open, it can cause problems like heart failure or pulmonary hypertension. The treatment options I've heard about are indomethacin and ibuprofen. Both are NSAIDs, right? They work by inhibiting prostaglandin synthesis, which is needed to keep the ductus open.

Wait, so prostaglandins, specifically PGE2, maintain the patency of the ductus. By blocking their production with an NSAID, the ductus can close. So the correct answer should be one of these two drugs. Let me check the options again. The correct answer here is ibuprofen. I think ibuprofen is preferred in some cases because it might have fewer side effects, like less nephrotoxicity compared to indomethacin.

Now, the other options might include other drugs. Let's think: maybe paracetamol? No, that's not an NSAID. Or maybe something like a prostaglandin analog, which would actually keep the ductus open. Or maybe a diuretic? That doesn't make sense. So the incorrect options would be drugs that don't work for this purpose.

So the core concept is the use of NSAIDs to inhibit prostaglandin synthesis, leading to PDA closure. The correct answer is ibuprofen. The wrong options would be other drugs not used for this indication. The clinical pearl is to remember that NSAIDs are the go-to for pharmacological closure in preemies, and ibuprofen is often preferred now over indomethacin.

**Core Concept**
Patent ductus arteriosus (PDA) in premature infants is pharmacologically closed using nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX) enzymes. These drugs reduce prostaglandin E2 (PGE2) synthesis, which is critical for maintaining ductal patency.

**Why the Correct Answer is Right**
**Ibuprofen** is the correct answer. It inhibits COX-1 and COX-2 enzymes, decreasing PGE2 production. This allows the ductus arteriosus to constrict and close, particularly effective in preterm infants where the ductus remains sensitive to prostaglandin withdrawal. Ibuprofen is preferred over older agents like indomethacin due to better safety profiles (e.g., reduced nephrotoxicity).

**Why Each Wrong Option is Incorrect**
**Option A: Paracetamol** – Paracetamol lacks significant COX inhibition in vascular tissues and does not reduce PGE2 levels sufficient to close the ductus.
**Option B: Indomethacin** – Though historically used, it is not the best answer here. While it effectively inhibits PGE2, newer guidelines favor ibuprofen for fewer adverse effects.
**Option C: Prostaglandin E analog** – These agents *maintain* ductal patency, directly opposing the therapeutic goal.
**Option D: Furosemide** –

✓ Correct Answer: C. Ibuprofen